Table 4.
Hypertensive Subjects |
Normotensive Subjects |
|||
---|---|---|---|---|
β | P | β | P | |
Multiple r2 | 0.58 | 0.42 | ||
cfPWV, mmHg | 0.458 | <0.001 | −0.342 | 0.152 |
The lowest nocturnal SBP, mmHg | Excluded variable | −0.275 | 0.270 | |
Morning SBP, mmHg | −0.047 | 0.834 | Excluded variable | |
Dip of night HR, beats/min | −0.290 | 0.040 | 0.181 | 0.482 |
Morning HR increase, beats/min | 0.093 | 0.660 | −0.590 | 0.088 |
Total activity, U/min | 0.036 | 0.799 | −0.163 | 0.540 |
Sympathetic BRS, bursts · 100 beats−1 · mmHg−1 | 0.332 | 0.023 | 0.198 | 0.467 |
Cardiovagal BRS phase IV, ms/mmHg | 0.057 | 0.668 | −0.508 | 0.075 |
cfPWV, carotid-to-femoral pulse wave velocity; BRS, baroreflex sensitivity.